In fact, the 36 survivors, with a median age of 50.7 years (range 29.5 69.5), who received cardiac-modifying medication had a Framingham Risk Score (FRS) and Systemic Coronary Risk Examination (SCORE) risk of 4.7% (interquartile range, IQR 0.8 2.7) and 7.9% (IQR 3.5 12.0), respectively, underscoring that Metabolic Syndrome (MetS) does indeed represent a risk factor for cardiovascular disease (CVD).
The authors do not report on the number of survivors who were on antihypertensive, lipid modifying and antidiabetic medication and whether those who were on these medications were excluded from the analysis in calculating the 10-year risk for CVD using the Framingham Risk Score (FRS) and Systemic Coronary Risk Examination (SCORE) predictive models.
It could be argued therefore that had CTCA been used in this group, approximately 25% of the invasive coronary angiography examinations which were subsequently proved to be normal could have been avoided.
The patient with shock vital did not permit a detailed examination, coronary angiography, or electrocardiogram-gated CT.
The excellent negative predictive value of a normal coronary CTA (cCTA) examination excludes the presence of significant coronary disease in the symptomatic patient.
For example, even though clinical materials like charts, videos generated by coronary angiography, and examination reports for a patient contain similar information, they are stored in different systems and managed by a patient ID without considering semantic relations.
Information taken from these case files included sex, height, weight, diagnosis on admission, discharge diagnosis, duration of hospital stay, hospital costs, history of smoking, past medical illness, family medical history, laboratory examination, coronary arteriography, cardiac ultrasound, complications, and drug treatment.
Fifty patients (31 men, 19 women, mean age: 55.6 years ±8.9) suspected of CAD undergoing coronary CT angiography examinations were included in the study.
Information was obtained from the records regarding medical treatment, referral to the HFC or the OPC after discharge, referrals for invasive examinations (coronary angiography) and invasive treatments (PCI, CABG, valve operation), and readmissions during the first years.
This approach may result in a post-test referral bias as a result of preferential selection of patients with a clear positive MPS examination for coronary angiography.
